Hims & Hers Health, Inc.·4

Apr 22, 5:24 PM ET

Boughton Soleil 4

4 · Hims & Hers Health, Inc. · Filed Apr 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Hims & Hers (HIMS) CLO Soleil Boughton Sells 9,463 Shares

What Happened
Soleil Boughton, Chief Legal Officer of Hims & Hers (HIMS), sold 9,463 shares on April 20, 2026 at $30.00 per share, for total proceeds of $283,890. This was a sale (disposition), not a purchase — sales by insiders are often routine and do not necessarily signal a change in company prospects.

Key Details

  • Transaction date: April 20, 2026; filing date (Form 4): April 22, 2026 (filed timely).
  • Trade: Sale of 9,463 shares at $30.00 each; total proceeds $283,890.
  • Transaction code: S (sale); method indicated: open market or private sale.
  • Shares owned after transaction: Not provided in the data supplied.
  • Footnote: The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

Context
A 10b5-1 plan means the sale was preplanned and scheduled, which can reduce the likelihood the trade was based on nonpublic information. For retail investors: insider purchases tend to be more informative than routine sales, and this filing appears consistent with a prearranged selling plan rather than a discretionary trade.

Insider Transaction Report

Form 4
Period: 2026-04-20
Boughton Soleil
Chief Legal Officer
Transactions
  • Sale

    Class A Common Stock

    [F1]
    2026-04-20$30.00/sh9,463$283,890299,368 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton|2026-04-22

Documents

1 file
  • 4
    wk-form4_1776893050.xmlPrimary

    FORM 4